Are you Dr. Cohen?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 18 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
300 Pasteur Drive
Stanford, CA 94305Phone+1 650-723-5315Fax+1 650-725-1536- Is this information wrong?
Summary
- Dr. Stanley Cohen, MD is an internist in Stanford, California. He is currently licensed to practice medicine in California. He is a Professor at Stanford University Medical Center.
Education & Training
- Duke University HospitalResidency, Internal Medicine, 1964 - 1965
- University of Michigan Health SystemResidency, Internal Medicine, 1961 - 1962
- Icahn School of Medicine at Mount SinaiInternship, Transitional Year, 1960 - 1961
- Perelman School of Medicine at the University of PennsylvaniaClass of 1960
Certifications & Licensure
- CA State Medical License 1968 - 2025
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 1988
Publications & Presentations
PubMed
- 2 citationsA Review of the Totality of Evidence for the Development and Approval of ABP 710 (AVSOLA), an Infliximab BiosimilarWalter Reinisch, Stanley N. Cohen, Monica Ramchandani, M. Khraishi, Jennifer Liu, Vincent Chow, Janet Franklin, Jean-Frederic Colombel> ;Advances in Therapy. 2021 Nov 10
- 1 citationsA Response to: Letter to the Editor Regarding A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWO...Stanley N. Cohen, Viatcheslav R. Akmaev, Johanna B. Withers, Erin Connolly-Strong> ;Rheumatology and Therapy. 2021 Nov 10
- 24 citationsCalpain-dependent cytoskeletal rearrangement exploited for anthrax toxin endocytosis.Sun-Young Jeong, Mikhail Martchenko, Stanley N. Cohen> ;Proceedings of the National Academy of Sciences of the United States of America. 2013 Oct 15
- Join now to see all
Press Mentions
- All or Something: Experts Debate LDA vs. Remission as a Target in Rheumatoid ArthritisApril 19th, 2022
- Is Methotrexate Necessary with Tofacitinib?June 18th, 2019
- EULAR 2019 - Day 1 ReportJune 12th, 2019